Skip to main content

Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.

Publication ,  Journal Article
Papalas, JA; Sebastian, S; Wang, E
Published in: Leuk Lymphoma
May 2011

Duke Scholars

Published In

Leuk Lymphoma

DOI

EISSN

1029-2403

Publication Date

May 2011

Volume

52

Issue

5

Start / End Page

905 / 907

Location

United States

Related Subject Headings

  • Mycosis Fungoides
  • Male
  • Lymphoma, T-Cell
  • Immunology
  • Humans
  • Genotype
  • Gene Rearrangement
  • Cell Transformation, Neoplastic
  • CD4 Antigens
  • Antibodies, Monoclonal
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Papalas, J. A., Sebastian, S., & Wang, E. (2011). Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides. Leuk Lymphoma, 52(5), 905–907. https://doi.org/10.3109/10428194.2010.551157
Papalas, John A., Siby Sebastian, and Endi Wang. “Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.Leuk Lymphoma 52, no. 5 (May 2011): 905–7. https://doi.org/10.3109/10428194.2010.551157.
Papalas, John A., et al. “Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.Leuk Lymphoma, vol. 52, no. 5, May 2011, pp. 905–07. Pubmed, doi:10.3109/10428194.2010.551157.

Published In

Leuk Lymphoma

DOI

EISSN

1029-2403

Publication Date

May 2011

Volume

52

Issue

5

Start / End Page

905 / 907

Location

United States

Related Subject Headings

  • Mycosis Fungoides
  • Male
  • Lymphoma, T-Cell
  • Immunology
  • Humans
  • Genotype
  • Gene Rearrangement
  • Cell Transformation, Neoplastic
  • CD4 Antigens
  • Antibodies, Monoclonal